Wakamoto Pharmaceutical Co.,Ltd. (WAKAMOTO PHARMACEUTICAL CO) aksje
4512.T
Forsinket 20 minWAKAMOTO PHARMACEUTICAL CO
Market Cap
$9,301,177,344
Om Wakamoto Pharmaceutical Co.,Ltd. (WAKAMOTO PHARMACEUTICAL CO) aksje
Wakamoto Pharmaceutical Co.,Ltd. engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Selskapsinformasjon
103-8330 Tokyo, Japan
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.